市場調查報告書
商品編碼
1034200

全球人造皮膚市場:增長、趨勢、預測(2020-2025)

Artificial Skin Market - Growth, Trends, and Forecast(2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

在預測期內,全球人造皮膚市場規模預計將以 5.6% 的複合年增長率增長。

推動人造皮膚市場增長的主要因素是急慢性傷口的日益流行以及對皮膚移植物的高需求。組織工程和生物技術等醫療技術的進步是人造皮膚市場的主要驅動力。

人們對各種皮膚護理的認識不斷提高,導致對人造皮膚的需求增加。交通事故、燒傷和創傷相關事故的增加也導致了人造皮膚市場的顯著增長。

本報告調查了全球人造皮膚市場、市場概況/結果、按產品類型/替代區域/材料/用途/最終用戶/地區、競爭形勢、主要我們提供公司簡介等的市場分析。

目錄

第 1 章介紹

第二章調查方法

第 3 章執行摘要

第 4 章市場動態

  • 市場概覽
  • 市場驅動因素
    • 醫療保健技術的進步
    • 越來越多的皮膚移植需求
    • 急慢性傷口發生率高
    • 提高對各種皮膚護理的認識
  • 市場限制
    • 治療費用高且無法報銷
    • 嚴格的監管標準
  • 波特五力分析

第 5 章市場細分

  • 按產品類型
    • 永久
    • 臨時
    • 複合
  • 按交換區
    • 真皮
    • 表皮
    • 配置
  • 按材料
    • 自然
    • 綜合
    • 兩者
  • 按應用程序
    • 急性傷口
    • 慢性傷口
    • 其他
  • 最終用戶
    • 醫院
    • 燒傷治療中心
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東/非洲
    • 南美洲

第6章競爭形勢

  • 公司簡介
    • Baxter International Inc
    • Convatec Group Plc
    • 3M Company
    • Smith and Nephew
    • Molnlycke Health Care AB
    • Integra Lifesciences Corporation
    • Medtronic
    • Paul hartmann AG
    • Solsys Medical, LLC.
    • MiMedX

第7章 市場機會與未來動向

目錄
Product Code: 71812

The Artificial Skin market studied is expected to grow with an anticipated CAGR of 5.6%, during the forecast period. The major drivers propelling the growth of the artificial skin market are the increasing prevalence of acute and chronic wounds and high demand for the skin grafts. The increasing advancements in the healthcare based technology such as tissue engineering technology and biotechnology has been the major driving force for the artificial skin market.

An increase in the awareness of various skin treatment procedures has lead to the rising demand for artificial skin. Artificial skin lacks immunogenic cells like dendritic cells, and hence auto rejection is not observed. The increase in the number of road accidents, burn and trauma related incidents has lead to a significant growth of the artificial skin market. According to WHO, Burns are the fourth most common type of trauma worldwide and nearly 96% of the fatal fire-related burns occur in middle and low-income countries. An estimated 265000 deaths across globe occur annually due to fire accidents alone. Considering the mentioned facts and key drivers, the artificial skin market is anticipated to propel over the forecast period.

Key Market Trends

Chronic wounds segment holds a substantial share in the market and is expected to increase over the forecast period

Chronic wounds include diabetic foot ulcers, venous leg ulcers and pressure ulcers. With the increase in the global geriatric population, diabetes and obesity, the prevalence of chronic wounds has been significantly increasing. The chronic wounds are affecting 5.7 million patients and costing approximately USD 20 billion annually in the United States. According to the International Diabetes Federation (IDF), approximately 463 million adults are living with diabetes and expected to rise to 700 million by 2045 and has lead to 4.5 million deaths in 2019. People with diabetes are at an increased risk of developing chronic wounds and infections. Diabetic foot and lower limb complications affect nearly 40 to 60 million people with diabetes globally. Hence, the prevalence of chronic wounds is expected to play a key role in the growth of the artificial skin market over the forecast period.

North America has a dominant share in Artificial Skin market and is anticipated to grow tremendously over the forecast period

In the United States, 3% of the population above 65 years of age are with chronic wounds. The US government estimates that the elderly population will reach 55 million by 2020, which is proportionate to the increasing chronic wound incidents. As per the Wound Healing Society (WHS), the cost of wound care is expected as USD 3.5 billion in the United States in 2019. The number of road accidents in the United States were 12 million in 2018. As per the National Safety Council, about 4.4 million were severely injured in 2018, which required major medical attention including skin treatments. As per the mentioned statistics and increasing geriatric population, diabetes and obesity related complication, North America is expected to propel in the artificial skin market over the forecast period.

Competitive Landscape

The Artificial Skin market is highly competitive and consists of significant major players, that dominate the market. Many small and medium-sized enterprises (SMEs) are also setting foot into the artificial skin market, thereby leading to an impactable growth over the forecast period. The major players in the Artificial Skin market are Integra Lifesciences Corporation, Smith & Nephew Plc, Molnlycke Health Care AB, Medtronic, 3M, Baxter International, MiMedX, Avita Medical, Mylan, Johnson and Johnson Services, Solsys Medical Inc., Paul Hartmann AG, Coloplast A/C and Convotec group Plc. The major players are evolving various strategies such as investment in Research and Development, collaborations and acquisitions. One such example is the acquisition of Acelity Inc. and its KCI subsidiaries, which is a global medical technology company focused on advanced wound management by 3M in Oct 2019.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Advancement in Healthcare Based Technology
    • 4.2.2 Elevated Need for Skin Grafts
    • 4.2.3 High Incidence of Acute and Chronic wounds
    • 4.2.4 Increasing Awareness on Various Skin Treatments
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Treatment and Lack of Reimbursements
    • 4.3.2 Stringent Regulatory Norms
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Permanent
    • 5.1.2 Temporary
    • 5.1.3 Composite
  • 5.2 By Replacement area
    • 5.2.1 Dermal
    • 5.2.2 Epidermal
    • 5.2.3 Composed
  • 5.3 By Material
    • 5.3.1 Natural
    • 5.3.2 Synthetic
    • 5.3.3 Both
  • 5.4 By Application
    • 5.4.1 Acute wounds
    • 5.4.2 Chronic wounds
    • 5.4.3 Others
  • 5.5 By End User
    • 5.5.1 Hospitals
    • 5.5.2 Burn care Centers
    • 5.5.3 Others
  • 5.6 Geography
    • 5.6.1 North America
      • 5.6.1.1 United States
      • 5.6.1.2 Canada
      • 5.6.1.3 Mexico
    • 5.6.2 Europe
      • 5.6.2.1 Germany
      • 5.6.2.2 United Kingdom
      • 5.6.2.3 France
      • 5.6.2.4 Italy
      • 5.6.2.5 Spain
      • 5.6.2.6 Rest of Europe
    • 5.6.3 Asia Pacific
      • 5.6.3.1 China
      • 5.6.3.2 Japan
      • 5.6.3.3 India
      • 5.6.3.4 Australia
      • 5.6.3.5 South Korea
      • 5.6.3.6 Rest of Asia-Pacific
    • 5.6.4 Middle East and Africa
      • 5.6.4.1 GCC
      • 5.6.4.2 South Africa
      • 5.6.4.3 Rest of Middle East and Africa
    • 5.6.5 South America
      • 5.6.5.1 Brazil
      • 5.6.5.2 Argentina
      • 5.6.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Baxter International Inc
    • 6.1.2 Convatec Group Plc
    • 6.1.3 3M Company
    • 6.1.4 Smith and Nephew
    • 6.1.5 Molnlycke Health Care AB
    • 6.1.6 Integra Lifesciences Corporation
    • 6.1.7 Medtronic
    • 6.1.8 Paul hartmann AG
    • 6.1.9 Solsys Medical, LLC.
    • 6.1.10 MiMedX

7 MARKET OPPORTUNITIES AND FUTURE TRENDS